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PRACTICE GUIDELINE

Organizational guidance for the
care of patients with head-and-neck
cancer in Ontario
J. Irish md msc,* J. Kim md,† J. Waldron md msc,‡ A.C. Wei md msc,§ E. Winquist md msc,||
J. Yoo md,# A. Boasie msc mba,‡** M. Brouwers phd,†† E. Meertens bscn mhsc,‡‡
S. McNair phd,§§ C. Walker-Dilks mls,§§ and the Expert Panel on Organizational
Guidance for the Care of Patients with Head and Neck Cancer in Ontario

ABSTRACT
Background At the request of the Head and Neck Cancers Advisory Committee of Ontario Health (Cancer Care
Ontario), a working group and expert panel of clinicians with expertise in the management of head-and-neck cancer developed the present guideline. The purpose of the guideline is to provide advice about the organization and
delivery of health care services for adult patients with head-and-neck cancer.

Methods

This document updates the recommendations published in the Ontario Health (Cancer Care Ontario)
2009 organizational guideline The Management of Head and Neck Cancer in Ontario. The guideline development
methods included an updated literature search, internal review by content and methodology experts, and external
review by relevant health care providers and potential users.

Results To ensure that all patients have access to the highest standard of care available in Ontario, the guideline
establishes the minimum requirements to maintain a head-and-neck disease site program. Recommendations are
made about the membership of core and extended provider teams, minimum skill sets and experience of practitioners, cancer centre–specific and practitioner-specific volumes, multidisciplinary care requirements, and unique
infrastructure demands.

Conclusions The recommendations contained in this document offer guidance for clinicians and institutions
providing care for patients with head-and-neck cancer in Ontario, and for policymakers and other stakeholders
involved in the delivery of health care services for head-and-neck cancer.

Key Words Ontario Health (Cancer Care Ontario), head-and-neck cancer, organizational guidelines
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INTRODUCTION
The purpose of this guideline is to provide advice about the
organization and delivery of health care services for adult
patients with head-and-neck cancer (not including thyroid
cancer). The recommendations establish the minimum
requirements to maintain a head-and-neck disease site
program. The recommendations are intended to ensure

www.current-oncology.com

that the proper infrastructure is in place and that medical,
nursing, allied health professional, and support staff are
experienced and properly trained. To ensure that all patients have access to the highest standard of care available
in Ontario, the recommendations establish standards for
minimum new-patient volumes for regional cancer centre
disease site groups.

Correspondence to: Jon Irish, c/o Cindy Walker-Dilks, Program in Evidence-Based Care, Cancer Care Ontario, Juravinski Hospital, 711 Concession Street, Hamilton,
Ontario L8V 1C3.
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METHODS
This report updates the organizational guidance portion
of the 2009 document The Management of Head and Neck
Cancer in Ontario1. A formal review of the guideline to
determine the continued relevance of the original recommendations and an updated literature search were
undertaken in 2017. Little new evidence emerged. A working
group was formed to address changes in the organization
and delivery of care to patients with head-and-neck cancer.
The recommendations are presented below, with additions
and modifications to the original version labelled as “new
2019” or “revised 2019.”

Research Questions
■

■

What minimum requirements are necessary for the
organization and delivery of multidisciplinary care to
patients with head-and-neck malignancies, including
advanced salivary and skin cancers, but not thyroid
cancer? Areas of interest include health care teams
and unique infrastructure.
What are the recommended staff requirements and
expertise required by medical, surgical, nursing, and
allied health care professionals to provide optimal care
for these patients with head-and-neck cancer? Areas
of interest include minimum volumes and training to
optimize patient outcomes.

Target Population

was intended to facilitate the dissemination of the final
guidance report to Ontario practitioners.
On 16 November 2018, the document was disseminated to 175 health care practitioners; the survey closed on
14 December 2018. Practitioners with relevant expertise
were identified in the pebc database of Ontario cancer care
practitioners, and other relevant contacts were provided
by the Ontario Society of Oral Maxillofacial Surgeons and
the Royal College of Dental Surgeons of Ontario. Lists of
speech–language pathologists and dietitians practising in
Ontario were provided by an expert panel member.
Results of the two sources of feedback can be found in
the full guideline report on the Ontario Health (Cancer Care
Ontario) [ oh ( cco )] Web site at https://www.cancercare
ontario.ca/en/guidelines-advice/types-of-cancer/58936.

RECOMMENDATIONS
Team
Multidisciplinary Care by Core Team (New 2019)
■

Core Team Membership (Revised 2019)

The population targeted in this guideline are adult patients who present with symptoms of, or who have been
diagnosed with, head-and-neck malignancies, including
advanced salivary and skin cancers, but not thyroid cancer.

■

Intended Users

■

This document is intended for administrators responsible
for maintaining, developing, and implementing headand-neck cancer programs, and for oncology health care
professionals who, during the full continuum of care from
diagnosis to post-treatment follow-up and rehabilitation,
interact with patients who have head-and-neck cancer.

■

Internal and External Review
For the internal review, an expert panel of clinical content experts reviewed the draft document and provided
feedback. Health care practitioners with expertise in the
guideline topic were invited to comment. Those individuals were drawn from the Ontario Head and Neck Cancers
Advisory Committee, the co-authors of the previous version
of this guideline, the database of Ontario cancer care practitioners maintained by the Program in Evidence-Based
Care ( pebc ), and recommendations by working group
members. Invitations were extended to 26 people, and 14
agreed to participate.
External review involved using professional consultation to solicit feedback from content experts about the
approved draft guideline. Relevant care providers and
other potential users of the guideline were contacted and
invited to provide feedback about the guideline recommendations through a brief online survey. That consultation
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Given the complexity of the disease and its associated
morbidities, all adult patients who present with symptoms of, or who have been diagnosed with, head-andneck cancer should be seen and cared for by a Core
Head and Neck Cancer Multidisciplinary Team before
any treatment is provided.

■

The Core Team is defined as the group of clinicians
who see most new patients with head-and-neck cancer
and who are responsible for the assessment, treatment,
planning, management, survivorship, and rehabilitation of those patients.
The care of patients with head-and-neck cancer should
be coordinated between the members of the Core Team
to ensure optimally effective and safe care.
During the diagnosis, management, and follow-up
process, each patient with head-and-neck cancer will
have a clearly identified most responsible physician
(mrp). The mrp refers to the physician who has overall
responsibility for directing and coordinating the headand-neck cancer care of an individual patient and the
management of their case at a specific point in time.
The mrp will be responsible for handover of care during
periods of absence or transition of care to a different
mrp or between treatment modalities.
The multidisciplinary team should comprise:
■
Surgical oncologist with experience managing the
entire scope of head-and-neck disease (early- to
late-stage cases)
■
Radiation oncologist
■
Medical oncologist
■
Pathologist with expertise in both histopathology
and cytopathology
■
Dentist with expertise in dental oncology
■
Clinical nurse specialist or nurse practitioner,
or both
■
Specialized oncology registered nurse (inpatient
and ambulatory registered nurses)
■
Medical imaging physician

Current Oncology, Vol. 27, No. 2, April 2020 © 2020 Multimed Inc.
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■
■
■
■

Speech–language pathologist
Registered dietitian
Social worker
Primary care physician
The primary care physician is not usually involved
in the day-to-day treatment of the patient with
head-and-neck cancer, but plays an important role
in post-treatment supportive care and is responsible for the ongoing overall health of the patient.
Based on circumstances, some primary care
physicians might be actively involved in the acute
care of patients with head-and-neck cancer, especially with regard to advocacy and coordination of
supportive care. Such involvement is encouraged.

Extended Team Membership (Revised 2019)
■

■

The Extended Team will be called upon by the Core
Team to facilitate treatment, planning, management,
survivorship, and rehabilitation of the patient. Members of the Extended Team provide more episodic care
and are not responsible for seeing most new patients.
Members of the Extended Team must have training
or experience managing patients with head-and-neck
cancers. The team comprises:
■
Anesthesiologist with expertise in airway management
■
Audiologist
■
Dental technicians and hygienists
■
Health care providers with expertise in gastrostomy creation, feeding tube placement, and support
for patients who require tube feeding
■
Home care team
■
Hyperbaric medicine
■
Interventional radiologist
■
Mental health providers, including psychiatrist
or psychologist
■
Occupational therapist
■
Ophthalmologist
■
Oral and maxillofacial surgeon
■
Pain management specialist
■
Palliative care specialist
■
Physiotherapist
■
Prosthodontist or prosthetic anaplastologist
■
Radiation physicist
■
Medical radiation technologist (radiation therapist)
■
Respiratory therapist

■
■

■

Minimal Skill Set and Experience for Treating
Head-and-Neck Carcinomas
Surgical Oncologist (Revised 2019)
■

A head-and-neck surgical oncologist must have expertise in and the ability to
■
investigate, diagnose, stage, restage, and treat
patients with head-and-neck cancer.
■
provide diagnostic testing that should include
■
imaging such as ultrasonography, contrastenhanced computed tomography, magnetic
resonance imaging, and positron-emission
tomography;
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the performance of point-of-care fine-needle
aspiration biopsy; and
■
direct tissue biopsy, with access to frozen section pathologic examination.
■
perform staging examinations, including
■
flexible nasopharyngoscopy in an ambulatory
care clinic,
■
panendoscopy and examination under general
anesthesia, and
■
open neck biopsy.
■
perform essential procedures to manage the upper aerodigestive tract and support patients with
head-and-neck cancer:
■
Tracheotomy
■
Rigid laryngoscopy
■
Rigid esophagoscopy
■
Nasogastric and percutaneous feeding tube
insertions (have the necessary access)
■
perform extirpative surgical procedures for the
treatment of skin, salivary gland, sinus or skull
base, oral cavity, laryngopharyngeal, and thyroid cancers, and for the management of cervical
lymph nodes.
■
provide minimally invasive oncologic procedures
such as endoscopic surgery or transoral robotic
surgery.
■
perform reconstructive surgical procedures that
include
■
nerve grafting (such as facial nerve);
■
skin and mucosal grafting; and
■
local, regional, and pedicle flap reconstruction.
■
be a member of a reconstructive team for which
microvascular reconstruction is readily available.
Surgeons must have completed advanced fellowship
training in head-and-neck surgical oncology.
Prerequisite to fellowship requires that candidates
■
attain the Royal College of Physicians and Surgeons of Canada (rcpsc ) Surgical Foundations
examination (or equivalent).
■
maintain a surgical case log to demonstrate sufficient competency relevant to the treatment of
patients with head-and-neck cancer.
■
successfully complete a rcpsc-approved surgical
residency (or equivalent).
Advanced fellowship training must
■
be of at least 1 years’ duration.
■
maintain a surgical case log to demonstrate sufficient proficiency in the foregoing list with respect
to “expertise and ability.”
■

Note: Advanced training is defined as an Advanced
Training in Head and Neck Oncologic Surgery Fellowship
through the Canadian Association of Head and Neck Surgical Oncology (https://cahnso.com/) or the American Head
and Neck Society (https://www.ahns.info/).

Head-and-Neck Microvascular Reconstructive
Surgeon (Revised 2019)
■

The head-and-neck microvascular reconstructive
surgeon is an integral member of the head-and-neck
oncology team.
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■

Advanced fellowship training in head-and-neck microvascular surgery is required.

■

Note: An individual surgeon may meet the training
standards and criteria as both a head-and-neck surgical
oncologist and a microvascular reconstructive surgeon.

Radiation Oncologist
■

■

Has completed a degree in medicine (or equivalent),
including the rcpsc Specialist Certificate in Radiation
Oncology (or equivalent).
Has enhanced knowledge and skill in the treatment
of patients with head-and-neck cancer, acquired from
either a formal clinical fellowship or significant clinical training in head-and-neck cancer treatment at an
expert centre during radiation.

Medical Oncologist
■

■

Has completed a degree in medicine (or equivalent),
including the rcpsc Specialist Certificate in Internal
Medicine (or equivalent), as well as the rcpsc Certificate of Special Competence in Medical Oncology
(or equivalent).
Has enhanced knowledge and skill in the treatment
of patients with head-and-neck cancer, acquired
from either a formal clinical fellowship or significant
clinical training in head-and-neck cancer treatment
at an expert centre during medical oncology residency
or fellowship.

Dentist with Expertise in Dental Oncology
■

Has completed a university-based degree in dentistry
and fulfilled the requirements of the Royal College of
Dental Surgeons of Ontario, and completed a 1-year
hospital residency program that includes training
and experience with patients who have head-andneck cancer, or an oral pathology or oral medicine
residency program approved by the Commission on
Dental Accreditation of Canada.

■

■

Advanced Practice Nurse (Clinical Nurse Specialist
or Nurse Practitioner)
■

■

Pathologist
■

■

Has completed a degree in medicine (or equivalent),
including the rcpsc Certificate of Special Competence
in Anatomical Pathology.
Has enhanced knowledge and skill in the pathology of
head-and-neck malignancies, acquired from either a
formal fellowship or significant training in head-andneck cancer at an expert centre.

Registered Nurse
■

All entry-to-practice nurses shall have a Bachelor’s
degree in nursing and be registered with the College of
Nurses of Ontario. Ideally, all nurses will hold a Certified
in Oncology Nursing (Canada) credential and membership in the Canadian Association of Nurses in Oncology.

Generalized and Specialized Oncology Nurses
■

Generalized and specialized oncology nurses have
enhanced specialty knowledge and skill, and practice
in an environment in which most individuals have a
diagnosis of cancer or are at risk of developing cancer.

e118

The registered nurse is able to
conduct a comprehensive health assessment, engage in supportive and therapeutic relationships
with patients and families, and manage cancer
symptoms and treatment side effects;
■
provide teaching, coaching, psychosocial–spiritual
support, and counselling across the continuum;
■
facilitate continuity of care and system navigation,
self-determination, and informed decision-making
for the individual or family; and
■
integrate best-practice or evidence-based knowledge in the care of patients and families2–4.
Ideally, a registered nurse working with this
patient population will have general oncology
experience or be mentored to develop the skills
to work with the patient population.
Specialized oncology nurses should be aligned and
integral to the care of this patient population in both
inpatient and outpatient or ambulatory care settings.
In ambulatory care, a primary registered nurse, case
management model, or head-and-neck site–specific
model should be established such that patients and
families will receive consistent care across the trajectory (diagnosis, treatment, and survivorship or palliation) and care settings (new-patient clinics, reviews,
and follow-up) for assessment, treatment planning,
symptom management, psychosocial support, and
long-term follow-up.
■

■

Advanced practice nurses should be aligned to any or
all of complex, specialized, or high-risk patient populations. The advanced practice nurse roles are designed
to address and meet the needs of individuals, families,
and groups of patients, and to have an impact at the
patient, organization, and system levels5.
The nurse practitioner should possess advanced
knowledge and skill to autonomously diagnose, order,
and interpret diagnostic tests; to prescribe treatment
(including drugs); and to perform specific procedures
within their legislated scope of practice6. The nurse
practitioner should support patients receiving concurrent treatment.
The clinical nurse specialist has a Doctoral or Master’s degree in nursing, with knowledge and expertise
in an area of cancer nursing. The breadth and depth
of knowledge is greater than that for the specialized
oncology nurse. The clinical nurse specialist functions
in the domains of direct clinical care, education, research, organizational leadership, and professional
development. The nurse practitioner, in addition to the
foregoing, has completed an approved post-Master’s
nurse practitioner specialty certificate, is registered
in the “extended class,” and has an expanded scope
of practice that includes ordering diagnostics, diagnosing, prescribing, treating, referring, and admitting
or discharging. The advanced practice nurse should
have prior oncology experience and expertise, but
might require role mentoring to develop specific
oncology expertise5,7,8.
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Medical Imaging Physician
■

■

The medical imaging physician has completed a degree in medicine (or equivalent), is a member of the
College of Physicians and Surgeons of Ontario, and
has completed the rcpsc 5-year residency program
and received a Certificate of Special Competence in
Diagnostic Radiology.
The residency should be followed by 1 or more years of
fellowship training in a subspecialty discipline.

Primary Care Physician
■

Oral and Maxillofacial Surgeon (New 2019)
■

The speech–language pathologist has a Master’s degree
(or equivalent) in speech pathology, is a registered member of the College of Audiologists and Speech–Language
Pathologists of Ontario, and is an independent authorizer with the Assistive Devices Program. Knowledge
and expertise in clinical swallowing assessment and
therapy, video fluoroscopic swallowing assessment,
and the management of patients with tracheotomies
is required. If required to do voice restoration work
for patients who have undergone laryngectomy, the
speech pathologist should be approved for delegated controlled acts and have specialized training in
tracheoesophageal puncture.

Registered Dietitian
■

■

■
■

■

The registered dietitian has a Bachelor’s degree in human nutrition and dietetics from a university program
that has been accredited by the Partnership for Dietetic
Education and Practice, and a post-degree supervised
practicum program accredited by the Partnership for
Dietetic Education and Practice.
Registration with the College of Dietitians of Ontario
is required; membership with the Dietitians of Canada
is recommended.
Hospital or patient care experience, or oncology expertise (or both) is recommended.
Registered dietitians complete detailed clinical nutrition assessments, develop individualized patient care
goals and a nutrition care plan, and provide ongoing
follow-up through the continuum of care.
The registered dietitian has experience and training
in nutrition support, with knowledge and expertise
in swallowing function and dysphagia assessment
and treatment.

Social Worker
■

■

■

The social worker has a Master’s degree in social work,
registration with the Ontario College of Social Workers
and Social Service Workers, and hospital or patient care
experience as well as oncology expertise.
Through a comprehensive psychosocial assessment,
social workers should have experience in understanding and treating the social, psychological, emotional,
spiritual, quality-of-life, and functional aspects of
cancer, working with patients and their caregivers
alike across the cancer care continuum.
Affiliation and membership with professional oncology social work organizations such as the Canadian
Association of Psychosocial Oncology and the Ontario Association of Social Workers are recommended.
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The oral and maxillofacial surgeon must have
expertise in dental rehabilitation and implant rehabilitation to support maxillofacial prostheses.
■
a degree in dentistry at an accredited dental
school, followed by postgraduate residency training and successful completion of specialty examinations administered by the National Dental
Examining Board of Canada of the Royal College
of Dentists of Canada.
■
a frcd ( c ) Certificate in Oral and Maxillofacial
Surger y, Fellowship Training Certificate (or
equivalent).
■
Royal College of Dental Surgeons of Ontario specialty certification as an oral and maxillofacial
surgeon.
■

Speech–Language Pathologist
■

The primary care physician has completed a degree
in medicine (or equivalent), ideally including a College of Family Physicians of Canada Certificate in
Family Medicine.

Volumes
Cancer Centre–Specific and Practitioner-Specific
Volumes (Revised 2019)
■

■

Innovative collaborations between high-volume and
low-volume centres or regions should be expanded
and defined to maintain the high quality of care being
provided to this group of patients. Such collaborations
include virtual multidisciplinary case conferencing
options and joint care planning with regional caredelivery models.
The development of small-volume, non-multidisciplinary
treatment programs for patients with head-and-neck
cancer should be strongly discouraged.

The human resources and proficiency volumes outlined in the subsections that follow are drawn from the
recommendations in the original guideline and from the
oh(cco) Head and Neck Standards—Designated Centre Requirements, which were developed by a multidisciplinary
steering committee in 2014 to operationalize the original
recommendations. No data are available in Ontario or
elsewhere to directly inform minimum volume thresholds
for surgeons, medical oncologists, or radiation oncologists
to ensure high-quality care. Additionally, no data or existing clinical practice guidelines in Ontario or elsewhere
are available to directly inform the minimum volumes for
specialized oncology nurses, advanced practice nurses,
speech–language pathologists, registered dietitians, or
social workers. The revised guideline working group believes that the volumes set out here are reasonable goals
in Ontario.

Recommended Minimum Volumes: Surgery
■

Each centre offering surgery should have a minimum
of 80 head-and-neck surgeries per year and a minimum of 2 head-and-neck surgical oncologists.
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■

■

If reconstructive microsurgeries are performed at a
centre, either by a head-and-neck surgical oncologist
or a plastic surgeon, the surgeon should perform a minimum of 20 reconstructive microvascular procedures
each year (the 20 reconstructive surgeries are included
in the 80-case volume).
Generally, head-and-neck cancer surgery cases should
be consolidated to a small number of specialized surgeons to ensure high quality of care.

Recommended Minimum Volumes:
Radiation Oncology
■

■

■

Optimally, all centres offering radiation to patients
with head-and-neck cancer should treat a minimum
of 100 patients per year and have a minimum of
2 radiation oncologists with expertise in head-andneck cancer.
However, radiation may be provided in centres that
treat a minimum of 50 patients per year if they meet
all the requirements for radiation services (including
2 radiation oncologists on site and necessary human
and physical resources) to accommodate patients who
live remotely. In that situation, it is expected that, to
optimize experience and treatment, both radiation
oncologists will be involved in the planning and management of all patients.
Generally, head-and-neck cancer cases should be consolidated to a small number of specialized radiation
oncologists to ensure high quality of care.

Recommended Minimum Volumes:
Systemic Therapy
■

■

■
■

Volumes for systemic therapy will generally be dictated
by radiation oncology volumes, because chemotherapy
is usually given concurrently with radiation.
Chemotherapy delivered concurrently with radiation
should be delivered only in centres in which the radiation is being given.
There should be a minimum of 2 medical oncologists
with expertise in head-and-neck cancers at that centre.
There is no volume requirement for patients receiving
palliative chemotherapy. Palliative chemotherapy
can be delivered at any regional systemic treatment
program site.

Recommended Minimum Volumes:
Allied Health Professionals
■

■

■
■
■

Specialized oncology nurse
■
1.0 full-time equivalent (fte) per 100 patients with
head-and-neck cancer
Advanced practice nurse
■
1.0 fte per head-and-neck site group (especially
with larger site groups seeing more than 200 patients in consultation per year or shared across
another site group)
Speech–language pathologist
■
1.0 fte per 150 patients with head-and-neck cancer
Registered dietitian
■
1.0 fte per 150 patients with head-and-neck cancer
Social worker
■
1.0 fte per 150 patients with head-and-neck cancer
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Multidisciplinary Care Requirements (New 2019)
■
■

■

■

■

Head-and-neck centres will provide surgery, radiation,
and systemic therapy.
All patients with head-and-neck cancer require a multidisciplinary assessment by a head-and-neck surgical
oncologist and a radiation oncologist with expertise
in head-and-neck oncologic cases at a minimum, and
should receive assessment by medical oncology as
needed. See the multidisciplinary cancer conference
guidance and information at https://www.cancercare
ontario.ca/en/guidelines-advice/types-of-cancer/286.
Where geography makes it difficult for patients to
travel to be seen in person, assessment must include
examination by an otolaryngologist or head-and-neck
surgeon who is available in the local community. In
addition, patients must be reviewed at a multidisciplinary case conference with a head-and-neck surgical
oncologist in attendance or by virtual review of the
images and clinical examination by a head-and-neck
surgical oncologist.
To allow care closer to home, radiation may be provided in centres not offering surgery if they meet all the
requirements for radiation services and are partnered
with a head-and-neck centre.
A “2-site” model is divided only by discipline and does
not refer to meeting volumes in one discipline (for
example, surgery or radiation) by spreading it across
2 hospitals. Each site is responsible for ensuring that
patients have access to all of the required human and
physical resources.

Unique Infrastructure Requirements (Revised 2019)
■

The head-and-neck oncologic program must function
within an acute-care hospital and be affiliated with
a regional cancer program. The program must have
access to regular ambulatory care facilities, diagnostic
and staging expertise and equipment, inpatient resources, and operating room access for cancer surgery.

Note: These requirements are unique to the treatment of
head-and-neck cancer and are beyond those requirements
that would typically be found in such settings.

Multidisciplinary Ambulatory Care Clinic
(New 2019)
■

■

Timely access to allied health professionals (speech–
language pathology, audiology, social work, nutrition,
oncology nursing)
Access to audiology services and assessment of middle
and inner ear function

Perioperative
■
■
■

Infrastructure for microvascular, laser, and minimally
invasive surgery
Rapid access to neurosurgery, thoracic surgery, and
vascular surgery intraoperative support
Perioperative monitoring (level iii or greater)—for example, specialized surgical nursing units with available 24-hour care, expertise in airway management,
and free flap monitoring
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■
■
■

Clinic equipment for nasopharyngoscopy and image
capture
Access to rigid laryngoscopy, esophagoscopy, bronchoscopy
Access to surgical pathology and frozen section

Medical Oncology
■
■

Ambulatory chemotherapy unit and oncology pharmacy support
Access to inpatient and ambulatory services, including
ability to administer chemotherapy

Radiation Oncology
■

Radiation treatment facility including these capabilities:
■
Linear accelerator–based external-beam radiation treatment with multileaf collimation and
intensity-modulated radiation therapy or volumetric-modulated arc therapy
■
Computed tomography simulation (with intravenous contrast available) and custom immobilization
■
Daily image-guided radiation therapy
■
Medical dosimetry and physics support for plan
development and quality assurance meeting or
exceeding provincial and national standards
■
Resources for staff and infrastructure to support
the acute and long-term patient experience, including access to all multidisciplinary programs

Diagnostic Imaging (New 2019)
■

■
■

Access to positron-emission tomography imaging for
insured indications (for current indications see: https://
www.petscansontario.ca/cms/One.aspx?portalId=
69866&pageId=69897#)
Ultrasound with access to point-of-care needle biopsy
Ancillary testing as required (for example, generalized
metastatic survey, bone scan, abdominal or pelvic
computed tomography, brain imaging)

Molecular Pathology and Testing for Human
Papillomavirus (New 2019)
■
■

Human papillomavirus status of squamous cell carcinomas of oropharynx
Epstein–Barr virus status of keratinizing and nonkeratinizing carcinomas of the nasopharynx

Nursing
■
■
■
■

■
■
■
■

Access to interventional radiology for insertion of
percutaneous endoscopic gastroscopy tubes
Feeding pumps for inpatient and ambulatory settings
Access to and support from vascular access programs
Access to space to see patients collaboratively and
independently from other team members, including
ability to assess drop-in patients and to manage afterhours care
Triage line access to support patients outside of clinic
hours
Access to acute-care services to manage acute patients
and systems to respond to medical emergencies
Drop-in clinics (for example, radiation nursing clinic,
urgent-care clinics)
Access to a nurse practitioner for patients receiving
concurrent treatment
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Speech–Language Pathology
■
■

■

Specialized equipment for speech rehabilitation
(post-laryngectomy)
Availability of and access to radiology for completion of
modified barium swallows and equipment to support
the analysis of swallowing function
Access to space to see patients collaboratively and
independently, including ability to assess drop-in
patients

Nutrition
■

■

Access to interventional radiology for insertion of a
radiology-inserted gastrostomy or access to the endoscopy suite for percutaneous endoscopic gastroscopy
Access to enteral feeding supplies for the delivery of
enteral nutrition

Dentistry (New 2019)
■
■
■
■

Capacity to support institutional volumes
Intraoral and extraoral (panoramic) or cone-beam
computed tomography imaging
Instrumentation, supplies, and staffing to quickly and
efficiently eliminate sources of infection
Instrumentation, supplies, and staffing to provide oral
surgical, operative, prosthetic or maxillofacial prosthetic, preventive, and follow-up dental care
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